Somatic Acupressure for Symptom Cluster Management in Breast Cancer Patients
Development and Preliminary Evaluation of an Evidence-based Somatic Acupressure Protocol for the Self-management of Symptom Cluster of Fatigue, Insomnia and Depression in Breast Cancer Patients
1 other identifier
interventional
51
1 country
1
Brief Summary
Using a robust research method following the MRC Framework, the proposed study will develop and test an evidence-based complementary health intervention to help breast cancer patients manage the fatigue-sleep disturbance-depression symptom cluster.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2019
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedStudy Start
First participant enrolled
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2022
CompletedJuly 21, 2022
July 1, 2022
1.2 years
September 27, 2019
July 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
FEASIBILITY: Eligibility rate
Eligibility rate as assessed by (the number of eligible participants / number of participants screened) x 100%
Immediately after completion of the intervention (T2)
FEASIBILITY: Recruitment rate
Recruitment rate as assessed by (the number of participants who participated in the study / number of eligible participants) x 100%
Immediately after completion of the intervention (T2)
FEASIBILITY: Retention rate
Retention rate as assessed by (the number of participants who completed the study / number of participants who enrolled in) x 100%
Immediately after completion of the intervention (T2)
FEASIBILITY: Attrition rate
Attrition rate as assessed by (the number of participants who dropped out after the randomization / number of participants who enrolled in) x 100%
Immediately after completion of the intervention (T2)
FEASIBILITY: subject recruitment
Feasibility of subject recruitment assessed by interviewing the participants' feedback regarding why they discontinued this study
Immediately after completion of the intervention (T2)
FEASIBILITY: Duration for completing the subject recruitment
Time period from the recruitment of first participants to the last patient: assessed by months
Immediately after completion of the intervention (T2)
ACCEPTABILITY: Actual days of acupressure
The number of days that the participants perform the SA interventions, where the scheduled sessions should be 7 weeks of daily acupressure
Immediately after completion of the intervention (T2)
ACCEPTABILITY: duration of each acupressure session
Duration of each time (minutes) of acupressure where the scheduled time per session should be around 36 minutes
Immediately after completion of the intervention (T2)
ACCEPTABILITY: SA protocol
Participants' feedback and satisfaction with the SA intervention assessed by a self-designed feedback form and follow-up semi-structured interviews
Immediately after completion of the intervention (T2)
FEASIBILITY: Questionnaire-Item-level missing value of each questionnaire
Item-level missing value of each questionnaire (%) assessed by the percentage of participants who do not answer any single item
Immediately after completion of the intervention (T2)
FEASIBILITY: Questionnaire-Scale-level missing value of the questionnaire
Scale-level missing value of the questionnaire (%) assessed by the percentage of participants who do not answer at least one item in the whole questionnaire
Immediately after completion of the intervention (T2)
SAFETY: adverse events
Number of adverse events occur during the intervention
Immediately once an adverse event occurs
Secondary Outcomes (4)
Fatigue
Data collection will be conducted at baseline (T1) and immediately after completion of the intervention (T2)
Sleep disturbance
Data collection will be conducted at baseline (T1) and immediately after completion of the intervention (T2)
Depression
Data collection will be conducted at baseline (T1) and immediately after completion of the intervention (T2)
Patients' quality of Life
Data collection will be conducted at baseline (T1) and immediately after completion of the intervention (T2)
Study Arms (3)
True SA (Somatic Acupressure ) group
EXPERIMENTALReceiving true somatic acupressure+usual care
Sham SA group
SHAM COMPARATORReceiving sham somatic acupressure+usual care
Usual care group
OTHERReceiving usual care only (an education booklet regarding knowledge of BC and FSD symptom cluster management advice)
Interventions
7-week self-acupressure plus usual care (an education booklet)
Same dose as the true acupressure group but on the sham acupoints plus usual care (an education booklet)
Usual care only (an education booklet)
Eligibility Criteria
You may qualify if:
- BC stage I to IIIa;
- have experienced at least a moderate level of the FSD symptom cluster, with a score of 4 or above on a 10-point numeric rating scale, from "0 (no symptom)" to "10 (worst symptom)", for each symptom during the past one month;
- have completed adjuvant chemotherapy for at least one month and up to three years;
- have not scheduled chemotherapy and radiotherapy during the whole study period;
- willing to participate in the RCT and provide written informed consent.
You may not qualify if:
- presently taking pharmaceutical agents to treat fatigue, sleep disturbance or depression, such as antidepressant medications, psychostimulants, or hypnotics;
- extremely weak and/or have cognitive impairment which make them unable (or difficult) to follow the study procedures and instructions;
- having the experience of any types of SAS treatment during the past six months;
- presently participating in any other research projects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital Of Southwest Medical University
Luzhou, Sichuan, 646000, China
Related Publications (1)
Wang T, Tan JB, Liu XL, Zheng SL, Zhao I, Eliseeva S, Polotan MJ, Cheng HL, Huang HQ. Implementing an evidence-based somatic acupressure intervention in breast cancer survivors with the symptom cluster of fatigue, sleep disturbance and depression: study protocol of a phase II randomised controlled trial. BMJ Open. 2022 Jan 20;12(1):e054597. doi: 10.1136/bmjopen-2021-054597.
PMID: 35058263DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing-Yu (Benjamin) Tan, PhD RN
Charles Darwin University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- This study can perform a partial blind design for participants in the true and sham intervention groups. Blind of outcome assessment will be also achieved in the true and sham intervention groups as all the questionnaires are patient-reported and the participants themselves will be the outcome assessors. Data analysis will be conducted by an independent statistician who are blinded to the group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2019
First Posted
October 8, 2019
Study Start
March 15, 2021
Primary Completion
May 17, 2022
Study Completion
July 20, 2022
Last Updated
July 21, 2022
Record last verified: 2022-07